A total 323 suspected COVID-19 Adverse Events Following Immunisation (AEFI), had been reported to the Medicines Control of Zimbabwe (MCAZ) as of July, 8 2022. By Michael Gwarisa This is out of a cumulative total of 6.3 million 1st doses and 4.6 million 2nd doses of COVID-19 vaccines that have been administered since the National Vaccination program was launched in February 2021. This translates to a rate of approximately 0.003% suspected adverse events (approximately 3 reactions for every 10 000 doses administered). 70% of these 323 AEFI reports were received…
Read More